Trials / Completed
CompletedNCT02252302
Exercise in Air Pollution and Lung Health in Asthmatics
The Effects of Inhaled Beta-2-Agonists and Air Pollution on Lung Function and Athletic Capacity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 19 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
When exposed to air pollution, the asthma symptoms are aggravated and lung function is impaired. Due to high breathing rates and volumes, physically active individuals are at particular risk of lung health impairment due to the high breathing rates and volumes. Greater doses of air pollutants reach deeper areas in the lungs where they can trigger asthma-symptoms. When treating these symptoms with inhaled beta-2-agonists the airways widen even more, allowing the air pollutants to reach even deeper areas of the lung. With this study the investigators investigate how inhaled beta-2-agonists affect athletic capacity and lung health in physically active asthmatics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Rest (Sitting on chair) | Study participants will sit on a chair for 60min. This is to simulate physical resting condition. |
| OTHER | Cycling exercise | Study participants will exercise on a cycle ergometer for 45min. Participants will start their 30-min long constant workload exercise test test 60-min after the drug intervention. The exercise test will be set to a resistance of 50% of the maximal wattage that was reached on the graded exercise test on the screening day. The cycling exercise intervention will follow the rest-intervention. |
| DRUG | Salbutamol inhalation | Study participants will be exposed to 400ug of salbutamol prior to entering the air pollution chamber. |
| DRUG | Placebo inhalation | Study participants will inhale a placebo (placebo for salbutamol) prior to entering the air pollution chamber |
| OTHER | Diesel Exhaust Exposure | Participants will be exposed to PM2.5 of 300 μg/m3 |
| OTHER | Filtered air | Participants will be breathing filtered air |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-08-01
- Completion
- 2021-05-01
- First posted
- 2014-09-30
- Last updated
- 2021-09-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02252302. Inclusion in this directory is not an endorsement.